ClinicalTrials.gov
ClinicalTrials.gov Menu

Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01692496
Recruitment Status : Unknown
Verified February 2016 by Grupo Espanol de Investigacion en Sarcomas.
Recruitment status was:  Active, not recruiting
First Posted : September 25, 2012
Last Update Posted : February 19, 2016
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Grupo Espanol de Investigacion en Sarcomas

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2016